Advanced search×

[Use of a feprazone-bromhexine combination in acute and chronic bronchopneumopathies].

Clin Ter 107(3):185-91 (1983) PMID 6362963

Version: za2963e q8za0 q8zbb q8zcb q8zde q8zea q8zf6 q8zg4

Similar articles you may find interesting…

  1. Effect of bromhexine on nasal mucus clearance in chronic maxillary sinusitis.

    Indian J Chest Dis Allied Sci 31(1):33-6 (1989) PMID 2807419

    Nasal mucus clearance (NMC) was studied in seventy patients with chronic maxillary sinusitis. Forty-five patients were treated with oral administration of bromhexine tablets along with oral antibiotics and nasal decongestants. Twenty-five patients received the same treatment but without bromhexine t...
  2. [The stability of bromhexine and the structure of its degradation products].

    Pharmazie 43(1):23-6 (1988) PMID 3375295

    Refluxed acid or neutral aqueous solutions of Bromhexine (1) show four degradation products. 1 is decomposed at room temperature (20 degrees C; 1 year) less than 1%. Degradation products of crystalline 1 are not detectable in the temperature-moisture-test. Under normal storage conditions a 5-year st...
  3. Kinetic and analytic investigations on the formation of N-nitroso-N-methyl-N-cyclohexylamine from bromhexine and nitrite.

    Arzneimittelforschung 38(9):1355-8 (1988) PMID 3272140

    Bromhexine (N-methyl-N-cyclohexyl-(2-amino-3,5-dibromobenzyl)-ammoniumhydr ochloride) forms N-nitroso-N-methyl-N-cyclohexylamine (NMCA) under the conditions of the WHO Nitrosation Assay Procedure (NAP-test). The formation kinetics of this compound was investigated. The formation of NMCA depends on t...